Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Free Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel transition-metal-free route for 2-aryl acetophenones. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108047118B reveals a metal-free synthesis of 3-indoleselenyl alcohols using elemental selenium, offering high purity and scalable production for pharma intermediates.
Patent CN109970789B reveals a metal-free route for triarylphosphine intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Patent CN107253967A enables transition-metal-free silylation for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN110372633B details a transition-metal-free reduction method using NaBEt3H, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Patent CN108314642B reveals a green triethylamine-based route for 2-methylpyridines. Offers cost reduction and scalable pharma intermediate manufacturing without heavy metals.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.